Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA). Different parts of the immune system have been targeted by monoclonal ...
Recent changes in both treatments and outcomes of rheumatoid arthritis (RA) in Japan were analyzed by viewing the 'National Database of Rheumatic Diseases by iR-net in Japan' registry, one of the ...
Nov. 13, 2024 — The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to ...
Rheumatoid arthritis (RA) is a systemic inflammatory disease characterised ... experienced 20% worsening from baseline in the SJC and TJC before week 8 could receive rescue treatment with tocilizumab ...
In fact, A recent survey of ours revealed that 54 percent of those surveyed agreed or strongly agreed that they would be interested in finding out about studies for new arthritis treatments. However, ...
The technology was announced at the JP Morgan Healthcare Conference in San Francisco. In this project, the stakeholders aim to use a human reference genome to combine with patient data in order to try ...
12 University of California, San Francisco/Synarc, San Francisco, California, USA 13 Synarc, Inc, San Francisco, California, USA Objectives: To assess the efficacy and safety of abatacept in ...
Yes to fighting for our community and against the challenges we face. Yes to making connections that count. Yes to advancing research for better treatments and a cure. Connect with and support people ...
The (AGA) has unveiled an updated clinical practice guideline in Gastroenterology addressing the prevention and management of hepatitis B virus reactivation (HBVr) in patients on immunosuppressive ...